Natasha Petry

18PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsGene and molecular therapyGeneral practiceMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 21, 2026
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population.

|Mar 09, 2026
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health System.

Kristen Jacobsen, Natasha J Petry, Max Weaver

|Jun 20, 2024
Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition.

Nina R Sperber, Megan C Roberts, Sarah Gonzales

|Jun 11, 2024
Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression.

Lindsay J Hines, Russell A Wilke, Rachel Myers

|May 09, 2024
Incidence of statin-associated muscle symptoms in patients taking statins with RYR1 or CACNA1S variants.

Natasha J Petry, Amanda Massmann, Megan Bell

|May 08, 2023
Impact of transitioning to an active, noninterruptive CYP2C19/proton pump inhibitor alert on prescribing patterns.

Amanda Massmann, Natasha J Petry

Pageof 3

Frequent Collaborators

3 joint publications

Jordan F Baye

3 joint publications

Amanda Massmann

3 joint publications

Laura Ramsey

3 joint publications

Sara L Van Driest